
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18986399
[patent_doc_number] => 20240058368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Respirable Polynucleotide Powder Formulations for Inhalation
[patent_app_type] => utility
[patent_app_number] => 18/121097
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18121097
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/121097 | Respirable Polynucleotide Powder Formulations for Inhalation | Mar 13, 2023 | Pending |
Array
(
[id] => 20100247
[patent_doc_number] => 20250230183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => MRNA CAP ANALOG AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/852777
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18852777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/852777 | MRNA CAP ANALOG AND USES THEREOF | Mar 9, 2023 | Pending |
Array
(
[id] => 18837874
[patent_doc_number] => 11845937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/181199
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 53
[patent_no_of_words] => 49408
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181199
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181199 | RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use | Mar 8, 2023 | Issued |
Array
(
[id] => 19961809
[patent_doc_number] => 12331296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Variant RNAi
[patent_app_type] => utility
[patent_app_number] => 18/169779
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 23390
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169779 | Variant RNAi | Feb 14, 2023 | Issued |
Array
(
[id] => 18673159
[patent_doc_number] => 20230310651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS FOR MODULATING RNA SPLICING
[patent_app_type] => utility
[patent_app_number] => 18/164350
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164350 | METHODS FOR MODULATING RNA SPLICING | Feb 2, 2023 | Abandoned |
Array
(
[id] => 19425251
[patent_doc_number] => 12084654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Methods for using transcription-dependent directed evolution of AAV capsids
[patent_app_type] => utility
[patent_app_number] => 18/160804
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 52
[patent_no_of_words] => 15855
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160804 | Methods for using transcription-dependent directed evolution of AAV capsids | Jan 26, 2023 | Issued |
Array
(
[id] => 19425250
[patent_doc_number] => 12084653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Methods for using transcription-dependent directed evolution of AAV capsids
[patent_app_type] => utility
[patent_app_number] => 18/160796
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 52
[patent_no_of_words] => 15859
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160796 | Methods for using transcription-dependent directed evolution of AAV capsids | Jan 26, 2023 | Issued |
Array
(
[id] => 18879482
[patent_doc_number] => 20240002851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/159465
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159465 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | Jan 24, 2023 | Pending |
Array
(
[id] => 18691074
[patent_doc_number] => 20230321281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/157589
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/157589 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | Jan 19, 2023 | Pending |
Array
(
[id] => 18649801
[patent_doc_number] => 20230295625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/148396
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148396
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148396 | Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products | Dec 28, 2022 | Issued |
Array
(
[id] => 18932513
[patent_doc_number] => 11884921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Signal boost cascade assay
[patent_app_type] => utility
[patent_app_number] => 18/078821
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 48
[patent_no_of_words] => 54331
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078821 | Signal boost cascade assay | Dec 8, 2022 | Issued |
Array
(
[id] => 18649796
[patent_doc_number] => 20230295617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/072296
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 204209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18072296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/072296 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | Nov 29, 2022 | Pending |
Array
(
[id] => 20262835
[patent_doc_number] => 12433803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Methods and compositions for studying cell evolution
[patent_app_type] => utility
[patent_app_number] => 18/057809
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057809 | Methods and compositions for studying cell evolution | Nov 21, 2022 | Issued |
Array
(
[id] => 20262835
[patent_doc_number] => 12433803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Methods and compositions for studying cell evolution
[patent_app_type] => utility
[patent_app_number] => 18/057809
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057809 | Methods and compositions for studying cell evolution | Nov 21, 2022 | Issued |
Array
(
[id] => 18693033
[patent_doc_number] => 20230323418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/056931
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056931 | Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use Thereof | Nov 17, 2022 | Pending |
Array
(
[id] => 20239663
[patent_doc_number] => 12419967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Polyinosinic--polycytidylic acid compositions and methods of making same
[patent_app_type] => utility
[patent_app_number] => 17/989526
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 26
[patent_no_of_words] => 24950
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989526 | Polyinosinic--polycytidylic acid compositions and methods of making same | Nov 16, 2022 | Issued |
Array
(
[id] => 19709554
[patent_doc_number] => 20250019696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => USE OF GANODERMA FUNGAL RNA MOLECULES, DRUG, DRUG COMPOSITION AND DELIVERY CARRIER
[patent_app_type] => utility
[patent_app_number] => 18/260789
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260789
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260789 | Use of ganoderma fungal RNA molecules, drug, drug composition and delivery carrier | Nov 16, 2022 | Issued |
Array
(
[id] => 20156977
[patent_doc_number] => 12383575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Polyinosinic--polycytidylic acid compositions
[patent_app_type] => utility
[patent_app_number] => 17/988625
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 40
[patent_no_of_words] => 32002
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988625 | Polyinosinic--polycytidylic acid compositions | Nov 15, 2022 | Issued |
Array
(
[id] => 18675552
[patent_doc_number] => 20230313160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITIONS AND METHODS FOR CONTROLLING BLOOD PRESSURE
[patent_app_type] => utility
[patent_app_number] => 18/054745
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054745 | COMPOSITIONS AND METHODS FOR CONTROLLING BLOOD PRESSURE | Nov 10, 2022 | Pending |
Array
(
[id] => 18365365
[patent_doc_number] => 20230146956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS
[patent_app_type] => utility
[patent_app_number] => 17/985005
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985005 | MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS | Nov 9, 2022 | Pending |